Logo
SearchSearch
Languages
Language
LoginSign up
Login
Invest in Travere Therapeutics Inc
Today
Create an eToro account to buy TVTX stock on a secure, user-friendly, multi-asset trading platform.
Buy Travere Therapeutics Inc
Buy Travere Therapeutics Inc
Travere Therapeutics Inc TVTX
Buy TVTX

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

Travere Therapeutics Inc News

Stocks-TVTX-Travere Therapeutics Inc

Travere Therapeutics Inc TVTX

$19.461.09(5.93%)(1D)

TVTX Stock Price Chart

16.28%
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset positive trend

The Travere Therapeutics Inc share price is rising this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Travere Therapeutics Inc share price today is 19.46, reflecting a 5.93% change over the last 24 hours and 13.69% over the past week. The current market capitalization of TVTX is 1.69B with an average volume in the last three months of 1.29M. The stock has a P/E ratio of -4.27 and a dividend yield of 0%. With the stock’s beta sitting at 1.18
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
$1.69B
Day’s Range
i
Shows the high and low prices of the day.
16.75 - 19.7
52W Range
i
Shows the high and low prices of the last year.
5.2 - 20.2
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
1.29M
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-4.27
Revenue
i
The total income generated by this company’s goods and services last year.
$203.45M
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
0 (0%)
Prev Close
i
The final price of this asset at the end of the last trading day.
$19.46
EPS
i
A company’s total earnings divided by the number of shares it has issued.
-4.56
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
1.18
What Is Travere Therapeutics Inc?
Travere Therapeutics Inc is at the cutting edge of bio-pharmaceuticals, designing innovative solutions for rare diseases. The firm operates on a global scale.

Part of the competitive pharmaceuticals and biotechnology sector, Travere Therapeutics develops innovative therapies. It strives to tackle rare diseases inadequately addressed by the current healthcare system. Travere Therapeutics is currently working on therapies for focal segmental glomerulosclerosis, classical homocystinuria and Alagille syndrome. It has recently got FDA accelerated approval of a therapy for IgA nephropathy.

Diversify your virtual portfolio by following TVTX shares on eToro.
Buy TVTX

How can I buy Travere Therapeutics Inc stocks?

To purchase Travere Therapeutics Inc:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Travere Therapeutics Inc (TVTX) page and place an order to buy Travere Therapeutics Inc.
Buy TVTX
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2024
Top Dividend Stocks for 2024
In times of market volatility, dividend investing provides investors with a steady source of income. eToro presents the top 6 dividend stocks to consider.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2024
AI Stocks Poised for Growth in 2024
Gear up for 2024 with a focus on AI stocks. Dive into the promising growth of C3.ai, Palantir Technologies, CrowdStrike, through eToro's expert analysis.
Read More
Go to the Academy >
Graph
Buy Travere Therapeutics Inc
Invest in Travere Therapeutics Inc
Today
Create an eToro account to buy TVTX stock on a secure, user-friendly, multi-asset trading platform.
Buy TVTX

FAQ

The current price of TVTX is 19.46.
The average price target for Travere Therapeutics Inc is 19.46. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Travere Therapeutics Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Travere Therapeutics Inc is 1.69B
Daily Movers
Explore the biggest stocks movers on the market.
Buy TVTX
Scroll to top